Age-specific direct healthcare costs attributable to diabetes in a Swedish population: A register-based analysis

Diabetic Medicine

Volumn 25, Issue 6, 2008, Pages 732-737

  Wirehn A B ^a,b   Andersson, A ^a,b   Ostgren C J ^a   Carstensen, J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Unit of Research and Development in Local Health Care   (Sweden)

Author keywords

Diabetes; Economics; Healthcare delivery; Prevalence; Registers

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DRUG COST; DRUG MARKETING; HEALTH CARE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INFANT; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; NEWBORN; POPULATION RESEARCH; PREVALENCE; SWEDEN; TEST STRIP;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; REGISTRIES; SWEDEN;

EID: 44649151693     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02444.x     Document Type: Article

References (21)

1. King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998 21 : 1414 1431.
2. Lipscombe L, Hux JE. Trend in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007 369 : 750 756.
3. Jönsson B. Revealing the cost of Type II diabetes in Europe. Diabetologia 2002 45 : S5 S12.
4. Ettaro L, Songer TJ, Zhang P, Engelgau MM. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 2004 22 : 149 164.
5. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003 26 : 917 932.
6. Chodick G, Heymann AD, Wood F, Kokia E. The direct medical cost of diabetes in Israel. Eur J Health Econ 2005 6 : 166 171.
7. Köster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany - the CoDiM Study. Diabetologia 2006 49 : 1498 1504.
8. von Ferber L, Koster I, Hauner H. Medical costs of diabetic complications total costs and excess costs by age and type of treatment results of the German CoDiM Study. Exp Clin Endocrinol Diabetes 2007 115 : 97 104.
9. Hodgson TA, Meiners MR. Cost of illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc 1982 60 : 429 462.
10. Rice DP. Cost-of-illness studies: fact or fiction? Lancet 1994 344 : 1519 1520.
11. Statistics Sweden. The Total Population Register. Sweden : Statistics Sweden, 2005. Available from http://www.ssd.scb.se/databaser/makro/start/asp. Last accessed 15 April 2007.
12. Wiréhn AB, Karlsson M, Carstensen J. Estimating disease prevalence using an administrative database. Scand J Public Health 2007 35 : 424 431.
13. Swedish Associationof of Local Authorities. Kostnad Per Patient (KPP) för bättre ledningsinformation i sjukvården. [Cost per Patient (CPP) for improving management information in health care.] Stockholm, 2002.
14. Östgren CJ, Engström S, Heurgren N, Borgquist L. Healthcare utilization is substantial for patients with type 2 diabetes in primary care: a patient-level study in a Swedish municipality. Eur J Gen Pract 2006 12 : 83 84.
15. Wettermark B, Hammar N, Michaelfored C, Leimanis A, Otterblad Olausson P, Bergman U et al. The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2006 7 : 726 735.
16. Kirkwood BR, Sterne JAC. Essential Medical Statistics, 2nd edn. Oxford : Blackwell Science Ltd, 2003.
17. Stock SA, Redaelli M, Wendland G, Civello D, Lauterbach KW. Diabetes - prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany. Diabet Med 2006 23 : 299 305.
18. Norlund A, Apelqvist J, Bitzen PO, Nyberg P, Schersten B. Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 2001 250 : 57 65.
19. Henriksson F, Agardh CD, Berne C, Bolinder J, Lönnqvist F, Stenström P et al. Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med 2000 248 : 387 396.
20. Eliasson M, Bostrom G. Chapter 5.2: major public health problems - diabetes. Scand J Public Health Suppl 2006 67 : 59 68.
21. Eliasson M, Lindahl B, Lundberg V, Stegmayr B. No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25-64 years of age in northern Sweden. Diabet Med 2002 19 : 874 880.